Clinical Trials Browser

INDUSTRY × Neutropenia × pegfilgrastim × Clear all

NCT03252431 2023-07-03

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 3 Completed

393 enrolled 20 charts

Breast Neoplasms, Neutropenia

NCT01724866 2022-04-15

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

Phase 2 Completed

148 enrolled 45 charts

Neutropenia

NCT02643420 2022-03-02

ADVANCE

Phase 3 Completed

406 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02953340 2022-03-02

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Phase 3 Completed

237 enrolled 18 charts

Breast Neoplasms, Neutropenia

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

Phase 3 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT01648322 2018-10-03

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 2 Completed

232 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT03404752 2018-01-19

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Phase 3 Unknown

Breast Neoplasms, Neutropenia

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Phase 3 Completed

847 enrolled 21 charts

Classical hematologyGastrointestinal

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

NCT01516736 2017-08-30

PROTECT2

Phase 3 Completed

308 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT01735175 2017-08-07

PROTECT-1

Phase 3 Completed

316 enrolled 20 charts

Breast Neoplasms, Neutropenia

NCT00364468 2017-03-03

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

Phase 2 Completed

Lymphoma, Neutropenia

NCT01519700 2015-05-06

PIONEER

Phase 3 Completed

218 enrolled 15 charts

Breast Neoplasms, Neutropenia

NCT00115193 2013-08-29

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Non-Hodgkin, Neoplasms, Neutropenia

NCT00035594 2013-05-09

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Phase 3 Completed

Breast Neoplasms, Neutropenia

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase 4 Completed

BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT00035620 2010-02-26

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Phase 2 Completed

Bone Neoplasms, Neutropenia, Sarcoma

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasms, Neutropenia

NCT00117897 2009-07-20

Treatment for Subjects With Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Non-Hodgkin, Neutropenia

NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia

NCT00114764 2008-10-31

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Neutropenia, Leukemia, Myeloid, Acute

NCT00115414 2008-08-01

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Phase 2 Completed

Breast Neoplasms, Fever, Neutropenia

NCT00117910 2008-05-16

Treatment for Elderly Patients With High Risk Breast Cancer

Phase 3 Completed

Breast Neoplasms, Neutropenia